✦ LIBER ✦

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

✍ Scribed by Gao, Chong; Hölscher, Christian; Liu, Yueze; Li, Lin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Key considerations in pharmacotherapy fo

✍ S. Cornell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 760 KB

Troglitazone: the discovery and developm

✍ Janice C Parker 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Elevated risk of type 2 diabetes for dev

✍ Butterfield, D. Allan; Di Domenico, Fabio; Barone, Eugenio 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 1024 KB

Targeting β-cell cyclic 3′5′adenosine mo

✍ Brian Furman; Nigel Pyne; Peter Flatt; Finbarr O'Harte 📂 Article 📅 2004 🏛 Pharmaceutical Press 🌐 English ⚖ 250 KB

Emerging Drugs and Targets for Alzheimer

✍ Martinez, Ana 📂 Article 📅 2010 🏛 Royal Society of Chemistry ⚖ 840 KB

Dapagliflozin: A Novel Sodium-Glucose Co

✍ Niren K. Shah; Wasim E. Deeb; Rushab Choksi; Benjamin J. Epstein 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB